James Treco insider trades
Open-market stock purchases and sales by James Treco, Director at Tonix Pharmaceuticals Holding Corp, from SEC Form 4 filings since May 6, 2019.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -67%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 12, 2026 | TNXP Tonix Pharmaceuticals Holding Corp | Bought (not open market) | — |
Companies traded
- TNXP Tonix Pharmaceuticals Holding Corp: 3 buys, last May 12, 2026